That depends on the announcement of CBD sales. But if it is news of the promised revenue source, this will speak volumes and should also protect from any pending future cap raisings, this will position MMJ Phytotech to become a non-dilutive revenue generating Medical Cannabis company. Speculative BioTechs are high-risk, this means you can either lose a lot or stand to make a lot. Invest cautiously and DYOR
MMJ Price at posting:
29.0¢ Sentiment: Buy Disclosure: Held
